RFEM’s Biosimilars Inter Partes Review (IPR) Dashboard By Nicole Gifford & Benjamin R. Holt on November 14, 2018 Email this postTweet this postLike this postShare this post on LinkedIn RFEM’s Biosimilars IPR Dashboard provides current information on IPR proceedings related to proposed biosimilar products.